Guy: And how does MIM approach or view that definition?
Alex: In the context of how we manage the business and given the required over-collateralization, securities lending is a low-risk market transaction in which liquid securities are exchanged for cash collateral. It is done for the purpose of generating incremental income from asset portfolios, thereby enhancing overall earned yield. It is a way to allow assets that are held in the general account, for liquidity or duration purposes, to work harder.
Guy: From a risk management perspective, how are lenders protected in such transactions?
Alex: This is the collateral component I referred to. To mitigate the risk of borrower default, collateral is critical to the transaction. Borrowers provide cash or other securities which exceed the value of the loaned assets. In the event the borrower fails to return the securities, this over-collateralization serves as a safeguard for the lender.
Guy: MIM’s approach clearly differs from the traditional model of a matched book.
Alex: That is correct. MIM prioritizes two key aspects: Liquidity and Capital Efficiency. This is most evident in our reinvestment strategy. Typically, lenders aim for a “matched book” approach, where the duration of the loan of securities aligns with the duration of the reinvested collateral. However, MIM employs a calculated “mismatch” strategy. In other words, we strategically reinvest the cash collateral with a longer weighted average life profile than the loaned collateral. This allows for potentially larger margins. What makes this strategy more liquid and capital efficient is the large allocation to high quality liquid assets (HQLA).
I would also note that the goal is to minimize loan balance volatility which enables us to maintain stable program balances. Stable balances allow us to express our reinvestment strategy.
Guy: What are the implications of such a difference? Is this how you generate extra yield beyond that of a “matched book”?
Alex: Our mismatched book is intended to generate a yield differential that we can capture but it introduces interest rate risk. So, if interest rates rise, this can negatively impact the fixed-rate reinvestment portfolio and potentially offset some of the gains from the “mismatch.”
Guy: So, it’s a calculated risk-reward proposition?
Alex: Indeed. MIM actively manages this risk by employing risk-reducing hedging strategies via interest rate derivatives, such as caps. These instruments act as a safeguard, limiting earnings margin erosion should interest rates experience a significant upward shift.
Guy: I bet this sophisticated approach requires constant vigilance.
Alex: Absolutely. While we believe MIM’s strategy has the potential to generate a superior and consistent income stream from our securities lending program, it necessitates proactive management and acknowledges the presence of additional risk factors. It may result in income volatility as a result of interest rate curve shifts, but managed prudently, the strategy has the potential for higher long-term income and higher margins vs traditional “matched book” lenders.
Guy: Could you elaborate further on some of the portfolio differences from a matched book?
Alex: As I mentioned, we seek higher collateral utilization rates which results in larger loan balances and ultimately higher adjusted earnings. Most agent lenders seek to prioritize the value of the collateral lent, resulting in lower program balances and utilization rates and ultimately lower income.
In addition, we seek to allocate a larger percentage to the HQLA segment of the portfolio, predominately U.S. Government Securities, which means lower allocation to credit assets vs. our peers. Our non-HQLA allocation prioritizes floating rate spread assets due to the favorable ALM profiles.
And lastly, most agent lender’s reinvestment strategies are limited to matched durations which can potentially lead to being overweight credit which carries its own set of risks.
Guy: Besides the extra potential yield what is the reason portfolio managers might be interested in this strategy?
We believe this approach is best suited for managers who are seeking to generate incremental income and comfortable with measured level of interest rate and credit risk. MetLife has a long history on both sides of the balance sheet, and we can tailor a prudent liability portfolio and diversified asset portfolio to meet a client’s objectives. The strategy also provides access to MIM’s unique asset organization capabilities.
Guy: Thank you for this comprehensive explanation, Alex. I now have a much clearer understanding of securities lending and the nuances of MIM’s approach within the broader context of portfolio optimization.
Disclaimer
This material is intended solely for Institutional Investors, Qualified Investors and Professional Investors. This analysis is not intended for distribution with Retail Investors.
This document has been prepared by MetLife Investment Management (“MIM”)1 solely for informational purposes and does not constitute a recommendation regarding any investments or the provision of any investment advice, or constitute or form part of any advertisement of, offer for sale or subscription of, solicitation or invitation of any offer or recommendation to purchase or subscribe for any securities or investment advisory services. The views expressed herein are solely those of MIM and do not necessarily reflect, nor are they necessarily consistent with, the views held by, or the forecasts utilized by, the entities within the MetLife enterprise that provide insurance products, annuities and employee benefit programs. The information and opinions presented or contained in this document are provided as of the date it was written. It should be understood that subsequent developments may materially affect the information contained in this document, which none of MIM, its affiliates, advisors or representatives are under an obligation to update, revise or affirm. It is not MIM’s intention to provide, and you may not rely on this document as providing, a recommendation with respect to any particular investment strategy or investment. Affiliates of MIM may perform services for, solicit business from, hold long or short positions in, or otherwise be interested in the investments (including derivatives) of any company mentioned herein. This document may contain forward-looking statements, as well as predictions, projections and forecasts of the economy or economic trends of the markets, which are not necessarily indicative of the future. Any or all forward-looking statements, as well as those included in any other material discussed at the presentation, may turn out to be wrong.
All investments involve risks including the potential for loss of principle and past performance does not guarantee similar future results. Property is a specialist sector that may be less liquid and produce more volatile performance than an investment in other investment sectors. The value of capital and income will fluctuate as property values and rental income rise and fall. The valuation of property is generally a matter of the valuers’ opinion rather than fact. The amount raised when a property is sold may be less than the valuation. Furthermore, certain investments in mortgages, real estate or non-publicly traded securities and private debt instruments have a limited number of potential purchasers and sellers. This factor may have the effect of limiting the availability of these investments for purchase and may also limit the ability to sell such investments at their fair market value in response to changes in the economy or the financial markets.
In the U.S. this document is communicated by MetLife Investment Management, LLC (MIM, LLC), a U.S. Securities Exchange Commission registered investment adviser. MIM, LLC is a subsidiary of MetLife, Inc. and part of MetLife Investment Management. Registration with the SEC does not imply a certain level of skill or that the SEC has endorsed the investment advisor.
For investors in the UK, this document is being distributed by MetLife Investment Management Limited (“MIML”), authorised and regulated by the UK Financial Conduct Authority (FCA reference number 623761), registered address One Angel Lane 8th Floor London EC4R 3AB United Kingdom. This document is approved by MIML as a financial promotion for distribution in the UK. This document is only intended for, and may only be distributed to, investors in the UK who qualify as a “professional client” as defined under the Markets in Financial Instruments Directive (2014/65/EU), as per the retained EU law version of the same in the UK.
For investors in the Middle East: This document is directed at and intended for institutional investors (as such term is defined in the various jurisdictions) only. The recipient of this document acknowledges that (1) no regulator or governmental authority in the Gulf Cooperation Council (“GCC”) or the Middle East has reviewed or approved this document or the substance contained within it, (2) this document is not for general circulation in the GCC or the Middle East and is provided on a confidential basis to the addressee only, (3) MetLife Investment Management is not licensed or regulated by any regulatory or governmental authority in the Middle East or the GCC, and (4) this document does not constitute or form part of any investment advice or solicitation of investment products in the GCC or Middle East or in any jurisdiction in which the provision of investment advice or any solicitation would be unlawful under the securities laws of such jurisdiction (and this document is therefore not construed as such).
For investors in Japan: This document is being distributed by MetLife Asset Management Corp. (Japan) (“MAM”), 1-3 Kioicho, Chiyoda-ku, Tokyo 102-0094, Tokyo Garden Terrace KioiCho Kioi Tower, a registered Financial Instruments Business Operator (“FIBO”) under the registration entry Director General of the Kanto Local Finance Bureau (FIBO) No. 2414, a regular member of the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association of Japan. As fees to be borne by investors vary depending upon circumstances such as products, services, investment period and market conditions, the total amount nor the calculation methods cannot be disclosed in advance. All investments involve risks including the potential for loss of principle and past performance does not guarantee similar future results. Investors should obtain and read the prospectus and/or document set forth in Article 37-3 of Financial Instruments and Exchange Act carefully before making the investments.
For Investors in Hong Kong S.A.R.: This document is being issued by MetLife Investments Asia Limited (“MIAL”), a part of MIM, and it has not been reviewed by the Securities and Futures Commission of Hong Kong (“SFC”). MIAL is licensed by the Securities and Futures Commission for Type 1 (dealing in securities), Type 4 (advising on securities) and Type 9 (asset management) regulated activities.
For investors in Australia: This information is distributed by MIM LLC and is intended for “wholesale clients” as defined in section 761G of the Corporations Act 2001 (Cth) (the Act). MIM LLC exempt from the requirement to hold an Australian financial services license under the Act in respect of the financial services it provides to Australian clients. MIM LLC is regulated by the SEC under US law, which is different from Australian law.
MIMEL: For investors in the EEA, this document is being distributed by MetLife Investment Management Europe Limited (“MIMEL”), authorised and regulated by the Central Bank of Ireland (registered number: C451684), registered address 20 on Hatch, Lower Hatch Street, Dublin 2, Ireland. This document is approved by MIMEL as marketing communications for the purposes of the EU Directive 2014/65/EU on markets in financial instruments (“MiFID II”). Where MIMEL does not have an applicable cross-border licence, this document is only intended for, and may only be distributed on request to, investors in the EEA who qualify as a “professional client” as defined under MiFID II, as implemented in the relevant EEA jurisdiction. The investment strategies described herein are directly managed by delegate investment manager affiliates of MIMEL. Unless otherwise stated, none of the authors of this article, interviewees or referenced individuals are directly contracted with MIMEL or are regulated in Ireland. Unless otherwise stated, any industry awards referenced herein relate to the awards of affiliates of MIMEL and not to awards of MIMEL.
1 MetLife Investment Management (“MIM”) is MetLife, Inc.’s institutional management business and the marketing name for subsidiaries of MetLife that provide investment management services to MetLife’s general account, separate accounts and/or unaffiliated/ third party investors, including: Metropolitan Life Insurance Company, MetLife Investment Management, LLC, MetLife Investment Management Limited, MetLife Investments Limited, MetLife Investments Asia Limited, MetLife Latin America Asesorias e Inversiones Limitada, MetLife Asset Management Corp. (Japan), and MIM I LLC, MetLife Investment Management Europe Limited and Affirmative Investment Management Partners Limited.
